HU200179B - Process for producing 7-square brackets open/meta-substituted/-phenylglycine-amido square brackets closed-1-carba-1-dethiacefems - Google Patents

Process for producing 7-square brackets open/meta-substituted/-phenylglycine-amido square brackets closed-1-carba-1-dethiacefems Download PDF

Info

Publication number
HU200179B
HU200179B HU874452A HU445287A HU200179B HU 200179 B HU200179 B HU 200179B HU 874452 A HU874452 A HU 874452A HU 445287 A HU445287 A HU 445287A HU 200179 B HU200179 B HU 200179B
Authority
HU
Hungary
Prior art keywords
formula
amino
acid
compound
chloro
Prior art date
Application number
HU874452A
Other languages
English (en)
Hungarian (hu)
Other versions
HUT45053A (en
Inventor
Robin D Cooper
John A Webber
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of HUT45053A publication Critical patent/HUT45053A/hu
Publication of HU200179B publication Critical patent/HU200179B/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D463/00Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16Nitrogen atoms
    • C07D463/18Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HU874452A 1986-10-03 1987-10-02 Process for producing 7-square brackets open/meta-substituted/-phenylglycine-amido square brackets closed-1-carba-1-dethiacefems HU200179B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91517386A 1986-10-03 1986-10-03

Publications (2)

Publication Number Publication Date
HUT45053A HUT45053A (en) 1988-05-30
HU200179B true HU200179B (en) 1990-04-28

Family

ID=25435354

Family Applications (1)

Application Number Title Priority Date Filing Date
HU874452A HU200179B (en) 1986-10-03 1987-10-02 Process for producing 7-square brackets open/meta-substituted/-phenylglycine-amido square brackets closed-1-carba-1-dethiacefems

Country Status (17)

Country Link
EP (1) EP0266896B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS6396186A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR880005125A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN87107149A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (2) ATE79119T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BG (1) BG47034A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3780909T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK518487A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI874311A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR3005920T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU200179B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE872646L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL84051A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ222015A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL151703B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT85850B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA877398B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ227842A (en) * 1988-02-05 1990-12-21 Lilly Co Eli Crystalline 2.5-hydrate form of a beta-lactam
US6982251B2 (en) 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
SK287988B6 (sk) 2001-01-26 2012-09-03 Schering Corporation Composition, oral dosage form and use thereof
AR035533A1 (es) 2001-01-26 2004-06-02 Schering Corp Uso de por lo menos un inhibidor de la absorcion de los esteroles o sus sales, solvatos, prodrogas farmaceuticamente aceptables o mezclas de los mismos para la preparacion de un medicamento para el tratamiento de la sitosterolemia, composiciones farmaceuticas, el uso de dichas composiciones para la
US7071181B2 (en) 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
DE60206365T2 (de) 2001-03-28 2006-07-06 Schering Corporation, Kenilworth Verfahren für die enantioselektive synthese von azetidinon-zwischenprodukten
AU2002336609B2 (en) 2001-09-21 2006-08-24 Merck Sharp & Dohme Corp. Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors
US7056906B2 (en) 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
US7053080B2 (en) 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
AU2003298513A1 (en) * 2002-05-14 2004-05-13 Northwestern University STERICALLY-AWKWARD Beta-LACTAMASE INHIBITORS
WO2004043457A1 (en) 2002-11-06 2004-05-27 Schering Corporation Cholesterol absorptions inhibitors for the treatment of autoimmune disorders
WO2004081002A1 (en) 2003-03-07 2004-09-23 Schering Corporation Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
US7459442B2 (en) 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
EP1601669B1 (en) 2003-03-07 2008-12-24 Schering Corporation Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
MXPA05009502A (es) 2003-03-07 2005-10-18 Schering Corp Compuestos de azetidinona sustituidos, formulaciones y usos de los mismos para el tratamiento de hipercolesterolemia.
CN102144992B (zh) * 2011-03-10 2013-04-10 浙江大学 苯基甘氨酸衍生物制备对金黄色葡萄球菌有抑菌和杀菌活性的抗菌剂的用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3697515A (en) * 1963-02-18 1972-10-10 Ciba Geigy Corp Process for splitting the 7-n-acyl group from cephalosporin compounds
NO155548C (no) * 1979-02-10 1987-04-15 Kyowa Hakko Kogyo Kk Fremgangsmaate til fremstilling av optisk aktive cefalosporin-analoger.
NO155547C (no) * 1979-02-10 1987-04-15 Kyowa Hakko Kogyo Kk Optisk aktive cefalosporin-analoge og salter derav samt fremgangsmaate for deres fremstilling.
JPS5672698A (en) * 1979-11-14 1981-06-16 Kyowa Hakko Kogyo Co Ltd Preparation of optically active cephalosporin analogue
JPS60174787A (ja) * 1984-02-21 1985-09-09 Kyowa Hakko Kogyo Co Ltd 3位置換カルバセフエム化合物
US4673737A (en) * 1985-08-02 1987-06-16 Harvard University 7-acylamino-(or 7-amino)-3-trifluoromethylsulfonyloxy-1-carba(1-dethia)-3-cephem-4-carboxylic acids and esters thereof

Also Published As

Publication number Publication date
DK518487A (da) 1988-04-04
FI874311L (fi) 1988-04-04
GR3005920T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-06-07
EP0266896A1 (en) 1988-05-11
BG47034A3 (bg) 1990-04-16
FI874311A0 (fi) 1987-10-01
FI874311A7 (fi) 1988-04-04
PT85850A (en) 1987-11-01
PL151703B1 (en) 1990-09-28
CN87107149A (zh) 1988-05-18
AT388377B (de) 1989-06-12
ATA257587A (de) 1988-11-15
ATE79119T1 (de) 1992-08-15
IL84051A0 (en) 1988-03-31
PT85850B (en) 1990-01-12
IE872646L (en) 1988-04-03
EP0266896B1 (en) 1992-08-05
JPS6396186A (ja) 1988-04-27
HUT45053A (en) 1988-05-30
DK518487D0 (da) 1987-10-02
AU7926987A (en) 1988-04-14
PL268034A1 (en) 1988-09-01
NZ222015A (en) 1989-10-27
DE3780909D1 (en) 1992-09-10
ZA877398B (en) 1989-05-30
AU591811B2 (en) 1989-12-14
DE3780909T2 (de) 1993-03-04
KR880005125A (ko) 1988-06-28

Similar Documents

Publication Publication Date Title
HU200179B (en) Process for producing 7-square brackets open/meta-substituted/-phenylglycine-amido square brackets closed-1-carba-1-dethiacefems
JPS638116B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA1051799A (en) Antibacterial agents
HRP920310A2 (en) Diasteromers 3-cephem-4-carbonic acid-1-(izopropoxycarbonyloxis) of ethyl esters and the process for obtaining them
HU184941B (en) Process for producing acyl derivatives of cepheme-carboxylic acids
JPH0269484A (ja) 新規セフェム化合物、その製造法及び抗菌剤
RU2073680C1 (ru) Кристаллические кислотно-аддитивные соли чистых диастереомеров 1-(2,2-диметилпропионилокси)-этилового эфира 3-цефем-4-карбоновой кислоты и способы их получения
WO1991007410A1 (en) Cephalosporin derivatives
US3868369A (en) 3-heterocyclicthiomethylcephalosporins
CS202056B2 (en) Process for preparing derivatives for preparing 7-aminocephalosporanic acid and ester thereof
HU204271B (en) Process for producing cristalline 1-carba-dethia-cepheme-solvates
US3953439A (en) Substituted phenylglycylcephalosporins
US3943129A (en) 7-Amino-3-(1,3,4-thiadiazolinylthio-methyl) cephalosporins
EP0349340A2 (en) Novel cephem compound, method for producing the same and anti-bacterial agent
JPH0246037B2 (ja) Sefuemujudotai
HU192003B (en) Process for producing indolyl-glycyl-cepheme derivatives
JP2002316992A (ja) 抗菌性の置換7−アシルアミノ−3−(メチルヒドラゾノ)メチルセファロスポリンおよび中間体
US3946005A (en) 7-Amino-3-(1,2,4-triazolinylthiomethyl)cephalosporins
US4490370A (en) Naphthylglycyl cephalosporin derivatives
US3957768A (en) 3-heterocyclicthiomethylcephalosporins
US4044047A (en) Intermediates for preparing substituted phenylglycylcephalosporins
US4073903A (en) 3-Desacetoxymethyl-3- 5'(1-methyltetrazolyl)thio!methyl-7- 1-(4-nitroimidazolyl)acetyl!aminocephalosporanic acid
JPS59184186A (ja) 新規セフエム化合物
US4133882A (en) 7-Hydroxyhalophenylacetamido-3-heterocyclicthiomethyl cephalosporins
EP0122155A2 (en) Improvements in or relating to naphthylglycyl cephalosporin derivatives

Legal Events

Date Code Title Description
HU90 Patent valid on 900628
HMM4 Cancellation of final prot. due to non-payment of fee